D. A. Kucheryavaya
D. A. Kucheryavaya has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Sergey A. Sterlikov
Russian Medical Academy of Continuous Professional Education
2 shared publications - Valentina A. Aksenova
National Medical Research Center of Phthisiopulmonology and Infectious Diseases; I. M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - A. V. Gordina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
1 shared publication - A.V. Gordina1 shared publication
- Irina A. Vasilyeva
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
1 shared publication - Yana Pankova
Russian Research Institute of Health, Ministry of Health of the Russian Federation, Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 9 December 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (11) , 13-19
Tuberculosis situation in children in 2021 and the prospects of its change in 2022
The article analyzes changes in the epidemic tuberculosis situation in children and factors influencing it. Data from tuberculosis statistical surveillance forms and on-line monitoring data for the biggest available period were studied. It was found that in 2021, tuberculosis incidence increased in children of 0-14 years old, and this increase was statistically significant (p < 0.05) in the group of children of 7-14years old (from 5.6 to 6.3 per 100,000 children of 7-14 years old), which may be related to the COVID-19 pandemic: increased epidemic risk of tuberculosis infection sources and increased exposure of children primarily of school age, who were switched to distant learning.The increase in tuberculosis incidence among children exposed to tuberculosis patients from 143.8 to 183.0 per 100,000 exposed children may be further attributed to decreased dissociating of contacts by hospitalizing children to tuberculosis sanatoria. Theepidemic tuberculosis situation in children is expected to deteriorate due to increased migration from the country with an unfavorable tuberculosis situation, i.e. Ukraine. Tuberculosis mortality in children continued to decline; there were no signs that it would increase in 2022.
- 9 December 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (11) , 13-19
Open AccessTuberculosis situation in children in 2021 and the prospects of its change in 2022
The article analyzes changes in the epidemic tuberculosis situation in children and factors influencing it. Data from tuberculosis statistical surveillance forms and on-line monitoring data for the biggest available period were studied. It was found that in 2021, tuberculosis incidence increased in children of 0-14 years old, and this increase was statistically significant (p < 0.05) in the group of children of 7-14years old (from 5.6 to 6.3 per 100,000 children of 7-14 years old), which may be related to the COVID-19 pandemic: increased epidemic risk of tuberculosis infection sources and increased exposure of children primarily of school age, who were switched to distant learning.The increase in tuberculosis incidence among children exposed to tuberculosis patients from 143.8 to 183.0 per 100,000 exposed children may be further attributed to decreased dissociating of contacts by hospitalizing children to tuberculosis sanatoria. Theepidemic tuberculosis situation in children is expected to deteriorate due to increased migration from the country with an unfavorable tuberculosis situation, i.e. Ukraine. Tuberculosis mortality in children continued to decline; there were no signs that it would increase in 2022.
- 11 October 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (5)
FREQUENCY RATE OF BCG VACCINATION AND SELECTED INDICATORS OF CLINICAL CHARACTERISTICS OF TUBERCULOSIS IN SCHOOL-AGE CHILDREN
Objective of the study: to assess the effect of the frequency of administration of the BCG vaccine on the nature and structure of clinical forms of tuberculosis (TB) in children. Materials and methods of research: a cohort observational retrospective continuous comparative multicenter crosssectional study was carried out. The data (registration form № 089/u-tube) of 3253 children of 7–14 years old with newly revealed changes in the lungs of a specific genesis, registered in 2019–2020 in the institutions of the anti-tuberculosis service of the Russian Federation were analyzed. Two comparison groups were identified: group 1 (observation group) – children who received a double injection of BCG vaccine (vaccination and revaccination) (n=184), group 2 (comparison group) – children who received a single BCG vaccination (n=3358). To achieve this goal, 5 null hypotheses were identified for testing which groups are formed from the received data array with the necessary parameters. The data were analyzed using univariate and multivariate analyzes (including confounding factors). Results: it was found that BCG revaccination does not reduce the risk of TB compared with residual changes after, it does not reduce the proportion of generalized forms of TB compared with localized forms (OR=2,4, p=0,08). The frequency of vaccination has not a statistically significant effect on the frequency of bacterial excretion (aOR=1,6, p=0,15) and destruction of lung tissue (OR=1,1, p=1). Revaccination has a statistically significant effect on the ratio of primary and secondary forms of TB, reducing the likelihood of its primary forms (aOR=0,4, p<0,001). In the course of multivariate analysis, it was found that the formation of primary or secondary TB, as well as the frequency of bacterial excretion in the comparison groups, was significantly influenced by confounding factors. Conclusion: this work has demonstrated the absence of a pronounced protective effect of repeated administration of the BCG vaccine on the clinical course of a specific process.
- 11 October 2021
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 100 (5)
FREQUENCY RATE OF BCG VACCINATION AND SELECTED INDICATORS OF CLINICAL CHARACTERISTICS OF TUBERCULOSIS IN SCHOOL-AGE CHILDREN
Objective of the study: to assess the effect of the frequency of administration of the BCG vaccine on the nature and structure of clinical forms of tuberculosis (TB) in children. Materials and methods of research: a cohort observational retrospective continuous comparative multicenter crosssectional study was carried out. The data (registration form № 089/u-tube) of 3253 children of 7–14 years old with newly revealed changes in the lungs of a specific genesis, registered in 2019–2020 in the institutions of the anti-tuberculosis service of the Russian Federation were analyzed. Two comparison groups were identified: group 1 (observation group) – children who received a double injection of BCG vaccine (vaccination and revaccination) (n=184), group 2 (comparison group) – children who received a single BCG vaccination (n=3358). To achieve this goal, 5 null hypotheses were identified for testing which groups are formed from the received data array with the necessary parameters. The data were analyzed using univariate and multivariate analyzes (including confounding factors). Results: it was found that BCG revaccination does not reduce the risk of TB compared with residual changes after, it does not reduce the proportion of generalized forms of TB compared with localized forms (OR=2,4, p=0,08). The frequency of vaccination has not a statistically significant effect on the frequency of bacterial excretion (aOR=1,6, p=0,15) and destruction of lung tissue (OR=1,1, p=1). Revaccination has a statistically significant effect on the ratio of primary and secondary forms of TB, reducing the likelihood of its primary forms (aOR=0,4, p<0,001). In the course of multivariate analysis, it was found that the formation of primary or secondary TB, as well as the frequency of bacterial excretion in the comparison groups, was significantly influenced by confounding factors. Conclusion: this work has demonstrated the absence of a pronounced protective effect of repeated administration of the BCG vaccine on the clinical course of a specific process.